Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.
作者信息
Vibert Eric, Boleslawski Emmanuel
机构信息
AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire; Inserm, Unité 1193, Université Paris-Saclay; Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, Villejuif, F-94800, France; DHU Hepatinov University Lille, CNRS, CHU Lille, UMR8161, Service de Chirurgie Digestive et Transplantations, CHU Lille, and Centre National de la Recherche Scientifique, Lille, France.
出版信息
Ann Surg. 2019 Jan;269(1):e5-e6. doi: 10.1097/SLA.0000000000002834.
PMID:29864091
Abstract
摘要
相似文献
1
Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.肝门部胆管癌的移植与切除术：关于可切除疾病治疗模式转变的争论
Ann Surg. 2019 Jan;269(1):e5-e6. doi: 10.1097/SLA.0000000000002834.
2
Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Paradigms for Resectable Disease in Annals of Surgery 2018.肝门部胆管癌的移植与切除术：《外科学年鉴》2018年中关于可切除疾病治疗模式转变的观点
Ann Surg. 2018 May;267(5):808-809. doi: 10.1097/SLA.0000000000002716.
3
ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma.ASO作者反思：肝门部胆管癌阳性胆管切缘的再次切除
Ann Surg Oncol. 2018 Dec;25(Suppl 3):784-785. doi: 10.1245/s10434-018-6856-0. Epub 2018 Oct 4.
4
Does caudate lobe resection really not improve the survival and outcomes in patients with hilar cholangiocarcinoma?尾状叶切除术真的不能改善肝门部胆管癌患者的生存率和预后吗？
Surgery. 2019 Nov;166(5):947-948. doi: 10.1016/j.surg.2018.09.014. Epub 2018 Nov 1.
5
Precision Hilar Cholangiocarcinoma Surgery.精准肝门部胆管癌手术
Ann Surg Oncol. 2018 May;25(5):1103-1104. doi: 10.1245/s10434-018-6416-7. Epub 2018 Mar 8.
6
[Operation treatment method of Bismuth-Corlette Ⅲ, Ⅳ hilar cholangiocarcinoma].[铋剂-柯莱特Ⅲ、Ⅳ型肝门部胆管癌的手术治疗方法]
Zhonghua Wai Ke Za Zhi. 2016 Jul 1;54(7):488-91. doi: 10.3760/cma.j.issn.0529-5815.2016.07.003.
7
Stent placement for hilar cholangiocarcinoma.肝门部胆管癌的支架置入术
Gastrointest Endosc. 2018 Mar;87(3):905-906. doi: 10.1016/j.gie.2017.11.017.
8
Surgical Treatment of Perihilar Cholangiocarcinoma: Resection or Transplant?肝门部胆管癌的外科治疗：切除还是移植？
Ann Surg. 2018 May;267(5):806-807. doi: 10.1097/SLA.0000000000002624.
9
Comprehensive treatment of advanced hilar cholangiocarcinoma: A case report.晚期肝门部胆管癌综合治疗：一例报告
Asian J Surg. 2023 Nov;46(11):5393-5394. doi: 10.1016/j.asjsur.2023.07.098. Epub 2023 Aug 2.
10
Re: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on incidence of intra- and extrahepatic cholangiocarcinoma in the United States.关于：肝门部胆管癌（克氏瘤）的分类对美国肝内和肝外胆管癌发病率的影响。
J Natl Cancer Inst. 2007 Mar 7;99(5):407; author reply 407-8. doi: 10.1093/jnci/djk068.
引用本文的文献
1
Prognostic and Predictive Molecular Markers in Cholangiocarcinoma.胆管癌的预后和预测分子标志物
Cancers (Basel). 2022 Feb 17;14(4):1026. doi: 10.3390/cancers14041026.
2
Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma.肝门周围及肝内胆管癌的当前外科治疗
Cancers (Basel). 2021 Jul 21;13(15):3657. doi: 10.3390/cancers13153657.
3
Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology.胆管癌作为移植肿瘤学时代肝移植的适应证
J Clin Med. 2020 May 5;9(5):1353. doi: 10.3390/jcm9051353.
Zotero 插件